Loading, please wait....jpg)
.jpg)
The Premier January 30, 2024 CE webinar will be held from 12 - 1 pm EST. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
ADALIMUMAB-SOS: NAVIGATING THE MARKET ENTRY OF ADALIMUMAB BIOSIMILARS IN THE US
SPEAKER: Stefanie Cisek, PharmD, BCACP, Clinical Pharmacist – Inflammatory, Specialty Medicine – Clinical Team Lead, Northwestern Medicine, Chicago, IL
ACPE Universal Activity Number 0122-0000-24-004-L01-P [0.1 CEU] [1 Contact Hr.]
Date: Jan 30, 2024 12:00 PM - 01:00 PM
Fee
CE Hours
CE Units
Registration closes on Jan 30, 2024 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
Registration closes on Jan 30, 2024
at 12:10 PM
Registration Closed
Objectives
- Review definitions pertaining to biologics and biosimilars, including interchangeability
- Compare the available adalimumab products
- Highlight opportunities for health system-based specialty pharmacies (HSSPs) to prepare for the launch of numerous adalimumab biosimilars that have come to market
- Describe the current and projected payor landscape for coverage of adalimumab products
- Identify strategies for HSSPs to consider when selecting if/when an adalimumab biosimilar is appropriate
Speaker(s)/Author(s)
|
Stefanie Cisek, PharmD, BCACP
|